| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Bicara Therapeutics Inc. (BCAX) have been net sellers, shedding 58,750 shares worth roughly $1.6M on balance.
BCAX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.60M | $73.65M | - | |
| CEO | 362.2K | $10.13M | - | |
| CEO | 181.6K | $4.26M | - | |
| CFO | 129.9K | $492.1K | - | |
| Other | 55.3K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 50,500 | $18.06 | $911,841.99 | -19.9% | -11.3% | -9.6% | |
| Sep 29, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE10b5-1 | 33,807 | $14.75 | $498,653.25 | - | +19.0% | +33.8% | |
| Sep 15, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE10b5-1 | 15,829 | $11.49 | $181,875.21 | - | +61.3% | +99.2% | |
| Jun 16, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE10b5-1 | 15,829 | $10.43 | $165,096.47 | - | +13.8% | +119.5% | |
| Mar 14, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE10b5-1 | 79,146 | $12.90 | $1,021,210.80 | - | -6.8% | +54.5% | |
| Sep 17, 2024 | Flynn James E62 | 10% Owner, Possible Members of 10% Group | Buy | 70,000 | $18.00 | $1,260,000.00 | +8.5% | -35.7% | -59.5% | |
| Sep 16, 2024 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 1,833,000 | $18.00 | $32,994,000.00 | +223.7% | -31.5% | -55.7% |